Literature DB >> 10207247

Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.

D A Fishman1, A Kearns, K Chilukuri, L M Bafetti, E A O'Toole, J Georgacopoulos, M J Ravosa, M S Stack.   

Abstract

Metastatic dissemination of epithelial ovarian carcinoma is thought to be mediated via tumor cell exfoliation into the peritoneal cavity, followed by adhesion to and invasion through the mesothelium which overlies the contents of the peritoneal cavity. In this study, we have utilized short-term primary cultures to analyze the effect of specific extracellular matrix proteins on properties of human ovarian epithelial carcinoma cells which contribute to the invasive phenotype. Analysis of cell:matrix adhesive profiles indicated that ovarian carcinoma cells adhere preferentially to type I collagen. Immunoprecipitation analyses demonstrated the presence of the collagen-binding alpha2beta1 integrin in biotin-labeled ovarian carcinoma cell membranes, and cellular adhesion was inhibited by blocking antibodies directed against the alpha2 and beta1 integrin subunits. The alpha2beta1-binding peptide Asp-Gly-Glu-Ala (DGEA) was also moderately effective at blocking adhesion to collagen relative to the control peptide Ala-Gly-Glu-Ala (AGEA). Analysis of cell motility on protein-coated colloidal gold coverslips demonstrated that ovarian carcinoma cells migrate preferentially on type I collagen coated surfaces. Type I collagen promoted migration in a concentration-dependent, saturable manner, with maximal migration observed at a collagen-coating concentration of 50 microg/ml. Migration on collagen was inhibited by antibodies directed against the alpha2 and beta1 integrin subunits and by DGEA peptide, providing evidence for the role of the alpha2beta1 integrin in ovarian carcinoma cell motility. Culturing ovarian carcinoma cells on type I collagen gels led to a significant increase in conversion of the matrix metalloproteinase 2 zymogen to the 66-kD form, suggesting that adhesion to collagen also influences matrix-degrading proteinases. These data suggest that alpha2beta1-integrin-mediated interaction of ovarian carcinoma cells with type I collagen, a protein prevalent both in the mesothelial extracellular matrix and in the peritoneal cavity of ovarian carcinoma patients, may function on multiple levels to promote metastatic dissemination of ovarian carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10207247     DOI: 10.1159/000024495

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  23 in total

1.  Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

Authors:  Sabrina Kellouche; Julien Fernandes; Johanne Leroy-Dudal; Olivier Gallet; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2010-02-24

2.  Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Authors:  Hui Li; Zhenwen Zhao; Caryl Antalis; Zhanzhong Zhao; Robert Emerson; Gang Wei; Sheng Zhang; Zhong-Yin Zhang; Yan Xu
Journal:  Am J Pathol       Date:  2011-05-17       Impact factor: 4.307

Review 3.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

Authors:  Juliette O A M van Baal; Cornelis J F van Noorden; Rienk Nieuwland; Koen K Van de Vijver; Auguste Sturk; Willemien J van Driel; Gemma G Kenter; Christianne A R Lok
Journal:  J Histochem Cytochem       Date:  2017-11-22       Impact factor: 2.479

4.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

5.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 6.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover.

Authors:  Neil O Carragher
Journal:  Clin Exp Metastasis       Date:  2008-10-29       Impact factor: 5.150

7.  Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.

Authors:  Joseph L Sottnik; Stephanie Daignault-Newton; Xiaotun Zhang; Colm Morrissey; Maha H Hussain; Evan T Keller; Christopher L Hall
Journal:  Clin Exp Metastasis       Date:  2012-12-15       Impact factor: 5.150

Review 8.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

Review 9.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

10.  Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.

Authors:  Thuy-Vy Do; Lena A Kubba; Hongyan Du; Charles D Sturgis; Teresa K Woodruff
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.